Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-Experienced Patients”

367 trials

Showing 20 of 367 results

Post-approval studies (Phase 4)Study completedNCT00207168
What this trial is testing

To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

Who this might be right for
AIDS
Bristol-Myers Squibb 120
Not applicableUnknownNCT00797381
What this trial is testing

Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia

Who this might be right for
HIV InfectionHemophilia A
Shanghai Public Health Clinical Center 100
Not applicableStudy completedNCT00016783
What this trial is testing

Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 39
Testing effectiveness (Phase 2)Study completedNCT00089466
What this trial is testing

Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Not applicableStudy completedNCT00002217
What this trial is testing

Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome
Not applicableStudy completedNCT01942213
What this trial is testing

Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.

Who this might be right for
Neovascular Age Related Macular Degeneration
Prism Vision Group 136
Testing effectiveness (Phase 2)Study completedNCT00027339
What this trial is testing

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 53
Testing effectiveness (Phase 2)Study completedNCT03132636
What this trial is testing

PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy

Who this might be right for
Carcinoma, Basal Cell
Regeneron Pharmaceuticals 138
Not applicableStudy completedNCT00551655
What this trial is testing

Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients

Who this might be right for
Human Immunodeficiency VirusesKidney FailureHIV Infections
AIDS Arms Inc. 684
Testing effectiveness (Phase 2)Ended earlyNCT00988442
What this trial is testing

Telephone Support to Improve Adherence to Anti-HIV Medications

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT05536973
What this trial is testing

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

Who this might be right for
Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 69
Testing effectiveness (Phase 2)Study completedNCT00053443
What this trial is testing

Handheld Computers to Improve Adherence to Anti-HIV Drug Regimens

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 156
Large-scale testing (Phase 3)Ended earlyNCT00612898
What this trial is testing

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

Who this might be right for
HIV Infections
Avexa 239
Early research (Phase 1)Study completedNCT00006509
What this trial is testing

The Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Large-scale testing (Phase 3)Study completedNCT00887679
What this trial is testing

Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS

Who this might be right for
Anxiety DisordersHIV Infections
Duke University 30
Not applicableUnknownNCT00787774
What this trial is testing

Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 20
Large-scale testing (Phase 3)Study completedNCT00554398
What this trial is testing

Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 69
Post-approval studies (Phase 4)WithdrawnNCT00854230
What this trial is testing

Pharmacotherapy for HIV Infected Patients With Alcohol Problems

Who this might be right for
HIV InfectionHeavy Alcoholic ConsumptionHIV Infections
VA Connecticut Healthcare System
Testing effectiveness (Phase 2)Study completedNCT00880763
What this trial is testing

Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 90
Post-approval studies (Phase 4)Study completedNCT00648999
What this trial is testing

Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

Who this might be right for
Human Immunodeficiency Virus
AbbVie (prior sponsor, Abbott) 207
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation